US 12,303,718 B2
Graphical representation of radiation therapy
Michael Kirk Owens, San Francisco, CA (US); Peter Demetri Olcott, Los Gatos, CA (US); and Rostem Bassalow, Lacey, WA (US)
Assigned to RefleXion Medical, Inc., Hayward, CA (US)
Filed by RefleXion Medical, Inc., Hayward, CA (US)
Filed on Sep. 20, 2021, as Appl. No. 17/479,873.
Application 17/479,873 is a continuation of application No. 16/582,308, filed on Sep. 25, 2019, abandoned.
Application 16/582,308 is a continuation of application No. 16/046,746, filed on Jul. 26, 2018, granted, now 10,456,600, issued on Oct. 29, 2019.
Claims priority of provisional application 62/537,422, filed on Jul. 26, 2017.
Prior Publication US 2022/0001209 A1, Jan. 6, 2022
Int. Cl. A61N 5/10 (2006.01); A61B 6/03 (2006.01); A61B 6/46 (2024.01)
CPC A61N 5/1071 (2013.01) [A61B 6/032 (2013.01); A61B 6/463 (2013.01); A61N 5/1045 (2013.01); A61N 5/1081 (2013.01); A61B 6/037 (2013.01); A61N 5/1067 (2013.01); A61N 2005/1074 (2013.01); A61N 2005/1076 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A method for monitoring radiotherapy, the method comprising:
(a) detecting acquiring PET imaging data of a target region using one or more PET detectors during the delivery of while delivering radiation for during a radiotherapy treatment session;
(b) calculating a dosimetric objective value using the acquired PET imaging data, wherein the dosimetric objective value represents a delivered radiation dose;
(c) comparing the dosimetric objective value with a range of acceptable dosimetric objective values for the radiotherapy treatment session; and
(d) generating a notification that indicates whether the dosimetric objective value is within the range of acceptable dosimetric objective values.